Skip to content

Retrospective/Prospective Data Collection on the LDR ROIA Interbody Fusion Device With VerteBRIDGE Plating

An Open Label, Multicenter, Clinical Study of the Safety and Efficacy of the LDR Spine ROI-A Interbody Fusion System Using the VerteBRIDGE™ Plating System

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02104141
Enrollment
51
Registered
2014-04-04
Start date
2013-11-30
Completion date
2016-12-31
Last updated
2019-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Disc Disease

Keywords

DDD, lumbar spine, fusion rate, degenerative disc disease

Brief summary

The purpose of this combination retrospective and prospective post market study is to examine the short term safety and efficacy of the ROI-A® interbody fusion device with VerteBRIDGE® plates to treat single and two-level degenerative disc disease between L2 and S1, with a focus on fusion rates and patient outcomes.

Interventions

DEVICEROIA Interbody Cage with VerteBRIDGE plating

Sponsors

LDR Spine USA
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects must have degenerative disc disease (DDD) of the lumbar spine between L2 and S1 * Subjects may have up to a Grade 1 spondylolisthesis at the involved level(s) * Subject must have the ROI-A® device at one level or at two contiguous levels between L2 and S1 only * Subject should have had a minimum of 6 months non-surgical treatment prior to receiving the ROI-A® device * Subject may have had NO MORE THAN two previous non-fusion surgeries to the lumbar spine at the same levels as the ROI-A® * Subject must be at least 21 years of age at the time of surgery * Subject must be willing to signed an informed consent document and return for a 12 month visit

Exclusion criteria

* Subject had more than Grade 1 spondylolisthesis at the operated level * Subject is a prisoner. * Subject was pregnant at the time of surgery. * Subject had an active infection or sepsis at the time of surgery.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Fusion12 months after device implantationFusion was assessed utilizing both AP and flexion/extension radiographs. Fusion was noted when all three of the criteria were present: 1) presence of bridging bone as identified by radiography, 2)Less than 5 degrees of segmental motion on flexion/extension radiographs, and 3) Less than 3 mm of A/P translation on flexion/extension radiographs

Secondary

MeasureTime frameDescription
Mean Oswestry Disability Index12 months after device implantationThe Oswestry Disability Index (ODI) is and index to quantify disability for low back pain. There are 50 possible points which are multiplied by 2 to arrive at a percentage score. Zero is equated with no disability and 100 is the maximum disability possible

Participant flow

Participants by arm

ArmCount
Operated Subjects
ROIA Interbody Cage with VerteBRIDGE plating
51
Total51

Baseline characteristics

CharacteristicOperated Subjects
Age, Continuous50.7 Years
STANDARD_DEVIATION 11.9
BMI (kg/mg^2)28.4 kg/mg^2
STANDARD_DEVIATION 4.6
Current smoker9 Participants
Previous Lumbar Spine Surgery19 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
4 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
47 Participants
Region of Enrollment
United States
51 Participants
Sex: Female, Male
Female
25 Participants
Sex: Female, Male
Male
26 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 51
other
Total, other adverse events
5 / 51
serious
Total, serious adverse events
0 / 51

Outcome results

Primary

Number of Participants With Fusion

Fusion was assessed utilizing both AP and flexion/extension radiographs. Fusion was noted when all three of the criteria were present: 1) presence of bridging bone as identified by radiography, 2)Less than 5 degrees of segmental motion on flexion/extension radiographs, and 3) Less than 3 mm of A/P translation on flexion/extension radiographs

Time frame: 12 months after device implantation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Operated SubjectsNumber of Participants With Fusion50 Participants
Secondary

Mean Oswestry Disability Index

The Oswestry Disability Index (ODI) is and index to quantify disability for low back pain. There are 50 possible points which are multiplied by 2 to arrive at a percentage score. Zero is equated with no disability and 100 is the maximum disability possible

Time frame: 12 months after device implantation

ArmMeasureValue (MEAN)Dispersion
Operated SubjectsMean Oswestry Disability Index28.9 score on a scaleStandard Deviation 22.3

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026